NeuroMetrix’s Quell neuromodulator gets FDA approval to treat fibromyalgia
The Quell neuromodulation device is said to be the first non-pharmacological treatment for fibromyalgia which received FDA Breakthrough…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
20 May 22
The Quell neuromodulation device is said to be the first non-pharmacological treatment for fibromyalgia which received FDA Breakthrough…
19 May 22
The approval will enable the firm to increase the availability of the MANTA device globally, and it gives…
17 May 22
The Cortrak* 2 EAS device has been designed to help health care professionals to place the medical feeding…
17 May 22
BELKIN's sight-saving technology could revolutionize first-line glaucoma care for the more than 100 million people who have glaucoma…
05 May 22
The multiplex test is based on Abbott’s advanced molecular PCR platform, the Alinity m system, for fast results…
04 May 22
The FDA’s Breakthrough Device status will enable the firm to speed up the development, evaluation, and review procedures…
04 May 22
The device is intended to treat symptoms like shortness of breath, cough, fatigue, joint and muscle pain, headaches,…
29 Apr 22
HealthOST is an AI software for spinal analysis of vertebral compression fractures and low bone density often associated…
26 Apr 22
Expected to launch in May 2022, the novel system addresses traumatic tendon lacerations in the hand, wrist, and…
22 Apr 22
The portable automated peritoneal dialysis (APD) system is claimed to be the lightest, smallest and quietest dialysis cycler…